Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Choroid plexus enlargement in acute neuroinflammation is tightly interrelated to the tyrosine receptor signalling
- The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
- Gray Matter alterations in MS and CIS: a Coordinate based Meta-analysis and regression
- The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis
- MRI evaluation of thalamic volume differentiates MS from common mimics
- Thalamic Iron Differentiates Primary-Progressive and Relapsing-Remitting Multiple Sclerosis
- Juxtacortical Lesions and Cortical Thinning in Multiple Sclerosis
- The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review
- Thalamus structure and function determine severity of cognitive impairment in multiple sclerosis
- Relationships between quantitative spinal cord MRI and retinal layers in multiple sclerosis
- Iron and Volume in the Deep Gray Matter: Association with Cognitive Impairment in Multiple Sclerosis
- Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study
- Accuracy of Postcontrast 3D Turbo Spin-Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis
- Evolution of Cortical and Thalamus Atrophy and Disability Progression in Early Relapsing-Remitting MS during 5 Years
- Brain atrophy and lesion load predict long term disability in multiple sclerosis
- Inhibition of Glutamate Carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis